What's Hot
View all perspectives
Eric Dein ericdeinmd
3 years 2 months ago
#ACR21 Abs#1442: JAKpot - Cycle JAK or switch to bDMARD after JAK failure?
▶️No difference between cycle vs bDMARD group
▶️Non-signif trends: cycled JAK better for inefficacy to 1st JAK, bDMARD better for adverse effects
@Rheumnow https://t.co/6UNUVh5ZW8 https://t.co/upfI6tDH1p
Aurelie Najm AurelieRheumo
3 years 2 months ago
First JAKi failure: What's next? Wanna find out? It's here
https://t.co/o5CE1MBzUu
Abstr#1442 #ACR21 @RheumNow https://t.co/f0sdPn5mcZ
Richard Conway RichardPAConway
3 years 2 months ago
Trauma associates with subsequent increased flares of SLE. Abstr#1446 #ACR21 @RheumNow https://t.co/QeNXOjHAjn
David Liew drdavidliew
3 years 2 months ago
Tell me there's no collegiality on the #ACR21 virtual platform!
kudos to @ACRheum for making this thing run so smoothly, year-on-year
(and I'm telling you, the value's in the chat and the questions)
@RheumNow @Janetbirdope https://t.co/XJZArHIdnc
Janet Pope Janetbirdope
3 years 2 months ago
Can you win the JAK pot twice? Equal effectiveness of JAK to JAK in #RheumatoidArthritis vs JAK to bDMARD. If d/c due to AE w JAK seemed to recur w 2nd JAK. Not RCT ?Channeling bias. But JAKi were worse off at baseline but did= switch v swap #ACR21 #ACRBest abst#1442 @RheumNow https://t.co/SRXMHdUBJF
Richard Conway RichardPAConway
3 years 2 months ago
Dr Jafarzadeh @Tuhina_Neogi on association NSAID use with TKR. At same level of pain, NSAID users appear to have more TKR. Is this same phenomenon we see with IA steroids (and tanezumab?)⬇️pain⬆️use⬆️damage? Abstr#1447 #ACR21 @RheumNow https://t.co/oY2ckmui0D
Richard Conway RichardPAConway
3 years 2 months ago
Long-term follow up of REDO study of ultra-low dose RTX (200mg vs 500mg vs 1000mg every 6 months) in RA. All doses appeared similarly effective, but also had similar adverse events. Potentially cost and time saving. Abstr#1443 #ACR21 @RheumNow https://t.co/0FRYPUOMpY
Eric Dein ericdeinmd
3 years 2 months ago
#ACR21 Ab#1443 by @NathandBroeder: Ultra-low dose RTX in RA?
⭐️RTX 200mg
▶️High retention in all groups- only 7 pts (6%) switched therapy. No diff in disease activity bw 200/500/1000mg
Great initial data, want more data on CD19/20, Ifns, etc.
@Rheumnow https://t.co/6UNUVh5ZW8 https://t.co/X1jCcw3h0I
Janet Pope Janetbirdope
3 years 2 months ago
?Save $ and ⬇️bad #COVID19 outcomes by using ultra low dose #Rituximab in #RheumatoidArthritis retreatmet after responding to 1g. Not quite same benefit and sl earlier repeat dosing. @RheumNow #ACR21 #ACRBest abst#1443 Impt study https://t.co/SFZKpTYJXP
TheDaoIndex KDAO2011
3 years 2 months ago
Way to go Texas!
#ACRknowledgebowl winners #GullsofGalveston when they answered the final jeopardy round: This monogenic dz can mimic Behcet’s syndrome and occurs due to mutation in TNFAIP3 @utmbhealth #ACR21 @rheumnow
...What is ...Haploinsufficiency A20? https://t.co/ExjKqtykVy
Richard Conway RichardPAConway
3 years 2 months ago
Dr Sherbini @james_gwinnutt @khyrich on baseline factors associated with nausea and alopecia with MTX. Alcohol use (modifiable!) and 👩 assoc with both. Disease activity with nausea. HAQ with alopecia. Abstr#1444 #ACR21 @RheumNow #ACRBest https://t.co/e0BG9omnEv
swethaann23 swethaann23
3 years 2 months ago
axSpA and Depression
71 axSpA patients surveyed
Abnormal HADs-D scores ▶️Significantly worse BASDAI and AQoL scores
Severe PHQ-9 scores ▶️worse BASDAI, BASFI and ASQoL
Abst# 1305 #ACR21 @RheumNow https://t.co/Sf2Rm6z7ln
Eric Dein ericdeinmd
3 years 2 months ago
#ACR21 Ab#1444 @AhmadSherbini. Factors ass w/ nausea & alopecia in MTX
⭐️Nausea & alopecia: ♀️, 🥃, activity score are risk factors
▶️EtOH highlights importance of folic acid in these pts!
@Rheumnow https://t.co/6UNUVh5ZW8 https://t.co/lxB2z2lXtu
Mrinalini Dey DrMiniDey
3 years 2 months ago
Rheumatology Research Foundation Lecture: Learning lessons from @Google to harness #omics to better understand #RA
#ACR21 @RheumNow @RheumResearch https://t.co/NVAe2Rqo1O
Janet Pope Janetbirdope
3 years 2 months ago
Love-hate relationship with #methotrexate. Side effects are common ex nausea/GI in 1/3 and alopecia in women. ?if you ask do you get more AES. Tough to treat especially SEs are early. ?Coach pt to help w persistence abst1444# @RheumNow #ACR21 https://t.co/NDQDVz8lk2
Poster Hall